Increasing product recall by regulatory authorities such as U.S. Food and Drug Administration can hamper the market growth over the forecast period. For instance, in May 2023, Becton, Dickinson and Company (BD), a medical device company, announced that the U.S. Food and Drug Administration had recalled its CD5 Series of Genesis Reusable Rigid Sterilization Container Systems, and has recommended the product to be discarded by any customers. The company stated that the products did not meet shelf-life testing requirements.
Market Opportunity – Increasing Adoption of Inorganic Growth Strategies
Increasing adoption of inorganic growth strategies such as agreements among key market players is expected to offer lucrative growth opportunities for the market growth. For instance, in December 2023, Biosero, a BICO, the bio convergence company and developer of laboratory automation solutions, announced that it had signed an agreement with a global life science company to design and build an automated R&D, hardware and software platform which consists of 5 sub-projects.
Clinical Microbiology Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients